The U.S. Supreme Court heard arguments Tuesday on a case challenging a federal rule over disproportionate share hospital (DSH) calculations [...] …
Articles by : Bella Czajkowski, National Correspondent
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Eli Lilly announced that it will refund 340B covered entities that purchased certain medications following adjustments to their ceiling prices. [...] …
Drugmakers Xellia Pharmaceuticals and Ascend Laboratories will refund 340B providers for some products following ceiling price recalculations, according to notices [...] …
AstraZeneca will discontinue a certain bottle dosage of its breast cancer drug Truqap (capiversatib) by the end of the year, [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
A California-based healthcare startup recently announced that it has raised more than $30 million, as part of a campaign with [...] …
Exclusive
Former Senior Trump Official Talks Drug Pricing Reform, Says 340B Program Is ‘Out of Control’
A key official in the former Trump administration raised serious concerns with the 340B program during the keynote address at [...] …
An influential drug industry expert said that he expects Johnson & Johnson (J&J) to sue the government over its refusal [...] …
Two community health centers urged a federal appeals court to overturn the dismissal of their 340B antitrust lawsuit, arguing in [...] …